QUCY
Mainz Biomed·NASDAQ
--
--(--)
--
--(--)
QUCY fundamentals
Mainz Biomed (QUCY) released its earnings on Aug 9, 2024: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), met estimates.
Revenue / YoY
--
--
EPS / YoY
--
--
Report date
Aug 9, 2024
EPS
Actual | -18 | -22.4 | -15.6 | -10.8 | |
Forecast | -19.6 | -16.8 | -18.9333 | -12.6667 | |
Surprise | +8.16% | -33.33% | +17.61% | +14.74% | 0.00% |
Revenue
Actual | 250.08K | 248.94K | 181.67K | 200.00K | -- |
Forecast | 266.67K | 283.33K | 333.33K | 253.33K | -- |
Surprise | -6.22% | -12.14% | -45.50% | -21.05% | 0.00% |
Earnings Call
You can ask Aime
What is Mainz Biomed's gross profit margin?What guidance did Mainz Biomed's management provide for the next earnings period?What does Mainz Biomed do and what are its main business segments?Did Mainz Biomed beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Mainz Biomed year over year?What factors drove the changes in Mainz Biomed's revenue and profit?What were the key takeaways from Mainz Biomed's earnings call?What were the key takeaways from Mainz Biomed’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
